**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 127-09-3 |Sodium acetate | 100 | 204-823-8 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Hygroscopic.
Potential Health Effects
Eye:
May cause mild eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract.
Inhalation:
May cause respiratory tract irritation.
Chronic:
Prolonged or repeated skin contact may cause irritation.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of soap and water for at
least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid.
Inhalation:
Remove from exposure to fresh air immediately. If not breathing,
give artificial respiration. If breathing is difficult, give oxygen.
Get medical aid if cough or other symptoms appear.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Dusts at sufficient concentrations can form
explosive mixtures with air. Combustion generates toxic fumes. Wear
appropriate protective clothing to prevent contact with skin and
eyes. Wear a self-contained breathing apparatus (SCBA) to prevent
contact with thermal decomposition products.
Extinguishing Media:
For small fires, use water spray, dry chemical, carbon dioxide or
chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Avoid generating dusty conditions.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation.
Storage:
Store in a cool, dry, well-ventilated area away from incompatible
substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Good general ventilation should be sufficient to control airborne
levels.
Personal Protective Equipment
Eyes:
Wear safety glasses with side shields.
Skin:
Wear appropriate gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A NIOSH/MSHA approved air purifying dust or mist
respirator or European Standard EN 149.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Appearance: white
Odor: Odorless to slightly acetic odor
pH: 8.9 @ 0.1M aq 25 C
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 324 deg C
Autoignition Temperature: 607 deg C ( 1,124.60 deg F)
Flash Point: Not available.
Explosion Limits, lower: N|A
Explosion Limits, upper: N\A
Decomposition Temperature: Not available.
Solubility in water: Soluble in water and alcohol.
Specific Gravity/Density: 1.528 g/ml
Molecular Formula: C2H3O2Na
Molecular Weight: 82.03
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents. Explosive mixtures may be formed with
fluorine or potassium nitrite.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, toxic fumes of sodium oxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 127-09-3: AJ4300010
LD50/LC50:
CAS# 127-09-3: Draize test, rabbit, eye: 10 mg Mild; Draize test,
rabbit, skin: 500 mg/24H Mild; Inhalation, rat: LC50 = >30 gm/m3/1H;
Oral, mouse: LD50 = 6891 mg/kg; Oral, rat: LD50 = 3530 mg/kg; Skin,
rabbit: LD50 = >10 gm/kg.
Carcinogenicity:
Sodium acetate -
Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Ecotoxicity:
Acute aquatic effects: 96-hour LC50 for fathead minnow: GT 100mg/L,
96-hour LC50 for water flea: GT 1000mg/L. This chemical has a low
potential to affect aquatic organisms.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Shipping Name: Not regulated.
Dangerous Goods Code:
UN Number:
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 127-09-3: 1
United Kingdom Occupational Exposure Limits
Canada
CAS# 127-09-3 is listed on Canada's DSL List.
CAS# 127-09-3 is not listed on Canada's Ingredient Disclosure List.
Exposure Limits
US FEDERAL
TSCA
CAS# 127-09-3 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 11/14/1997 Revision #1 Date: 8/02/2000
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Acetic Acid, Sodium Salt, Anhydrous, P.A.
| 127-09-3 |
|
1400W.dihydrochloride
| 0-01-1 |
|
4,5-Imidazoledicarboxylic Acid, 99% (Titr.)
| 570-22-9 |
|
S-Ethyl-N-[4-(trifluoromethyl)phenyl]-isothiourea.hydrochloride
| 0-01-1 |
|
L(+)-2-Amino-4-Phosphonobutyric Acid
| 23052-81-5 |
|
(+-)-1-Aminoindane-1,5-Dicarboxylic Acid
| 0-01-1 |
|
D(-)-2-Amino-4-Phosphonobutyric Acid
| 78739-01-2 |
|
DL-2-Amino-4-Phosphonobutyric Acid
| 20263-07-4 |
|
L-(+)-2-Amino-3-Phosphonopropionic Acid
| 23052-80-4 |
|
D-(-)-2-Amino-3-Phosphonopropionic Acid
| 128241-72-5 |
|
Ethyl 4-aminobenzoate, 98%
| 94-09-7 |
|
Acetic acid, sodium salt trihydrate, p.a.
| 6131-90-4 |
|
Benzoic acid, sodium salt, 99+%
| 532-32-1 |
|
DL-2-Amino-3-Phosphonopropionic Acid
| 20263-06-3 |
|
cis-Azetidine-2,4-dicarboxylic acid
| 121050-04-2 |
|
(+-)-trans-Azetidinen-2,4-Dicarboxylic Acid
| 0-01-1 |
|
(2R,4R)-(+)-Azetidinen-2,4-Dicarboxylic Acid
| 161596-63-0 |
|
(2S,4S)-(-)-Azetidinen-2,4-Dicarboxylic Acid
| 0-01-1 |
|
Sodium Bicarbonate, P.A.
| 144-55-8 |
|
(RS)-4-Bromo-homo-ibotenic acid
| 71366-32-0 |
|
Sodium borohydride, pellets, 7/16'', 98% (12-13 mm)
| 16940-66-2 |
|
Sodium Bromate, 99+%
| 7789-38-0 |
|
Ammonium Thiocyanate
| 1762-95-4 |
|
3-Cyclohexyl-1-Propanol, 99%
| 1124-63-6 |
|
(2S,3S)-Trans-3-(Carboxymethyl)-Azetidine-2-Acetic Acid
| 185387-36-4 |
|
Sodium bromide, p.a.
| 7647-15-6 |
|
4-(Trifluoromethoxy)benzonitrile
| 332-25-2 |
|
Diltiazem.hydrochloride
| 33286-22-5 |
|
FGIN-1-27
| 142720-24-9 |
|
Dimethyl 2-acetoxyethylphosphonate
| 39118-50-8 |
|
6-alpha-Methylprednisolone, 99%
| 83-43-2 |
|
L-Cysteine hydrochloride hydrate, 98.5%- 101.5% (on the dried basis)
| 52-89-1 |
|
5-Norbornene-2-carboxaldehyde, 90-95%
| 5453-80-5 |
|
Glipizide (USP)
| 29094-61-9 |
|
(+-)-Ibotenic acid
| 2552-55-8 |
|
IDRA 21
| 22503-72-6 |
|
Sodium Carbonate, Anhydrous
| 497-19-8 |
|
1,5-Isoquinolinediol
| 5154-02-9 |
|
Luzindole
| 117946-91-5 |
|
N-Methyl-L-Aspartic Acid
| 4226-18-0 |
|
N-Methyl-D-aspartic acid
| 6384-92-5 |
|
p-Iodophenoxyacetic acid, 97%
| 1878-94-0 |
|
Ammonium meta-vanadate
| 7803-55-6 |
|
Sodium carbonate monohydrate, reagent ACS (granular)
| 5968-11-6 |
|
Sodium chlorate, 99+%
| 7775-09-9 |
|
4-n-Heptyloxybenzoic Acid, 98%
| 15872-42-1 |
|
(S)-(-)-N-(2-Hydroxyethyl)-Alpha-Phenylethylamine, 99%
| 0-01-1 |
|
4-Chlorobutyryl chloride, specialty project grade
| 4635-59-0 |
|
3-Hydroxy-2-methylpyridine, 99%
| 1121-25-1 |
|
Sodium borohydride, powder, 98+%, Morton material !!!Prepak only!!!
| 16940-66-2 |
|
|